We refer to our announcements made on 4 November 2020, 9 November 2020, 18 March 2021 and 18 June 2021 in relation to the Memorandum of Understanding (“MOU”) entered between HS Bio Sdn. Bhd. (formerly known as HS Bio Supplies Sdn. Bhd.) (“HS Bio”) (a wholly-owned subsidiary of the Company) with Beijing Applied Biological Technologies Co., Ltd (“XABT”) (“Announcements”), unless otherwise defined, the definitions set out in the Announcements shall apply herein.

As stated in the announcement dated 18 March 2021, HS Bio had on 12 January 2021 obtained an Establishment License issued by the Medical Device Authority, the Ministry of Health Malaysia (“MOH”) with a validity period from 12 January 2021 until 11 January 2024 to act as an authorised representative, distributor and importer of medical and healthcare products in Malaysia.

The MOU was intended for the Parties to obtain the relevant approval from the MOH for the registration of XABT’s 2019-nCoV PCR test kit in Malaysia. Further to the special access approval as granted by the Medical Device Authority of MOH to HS Bio on 22 March 2021, XABT had agreed for HS Bio to act as their local partner in Malaysia for the distribution of their products in Malaysia. Subsequently, HS Bio had commenced to procure their products to supply to authorised laboratories in Malaysia.

This announcement is dated 20 September 2021.